Physicians and technologists need current information and data to make informed decisions regarding MR contrast agents. Accordingly, experts on contrast media have been assembled to present the latest data with the use of GBCAs. MR has become a routine tool used to improve diagnostic performance and guide appropriate treatment. As such, the MR community is challenged with maintaining current knowledge of trends and advances that could impact decision-making. The goal of this CME/CE-accredited educational enduring series is to educate clinicians on the usage and value of GBCAs in MR imaging, convey key information on contrast agent selection and usage while understanding the benefits of a high relaxivity option. The potential value of high relaxivity at different field strengths including 1.5T and 3T MR equipment but also new low and ultra-low field new scanners in the different MR indications including pre-operative staging, post neoadjuvant chemotherapy, post-surgical evaluation (surgical margins, breast conservation therapy).